Jeff E. Knight, COO of Crinetics Pharmaceuticals ($CRNX), made two open market sales of company stock over the past year, totaling about $245,000. His latest sale occurred on March 19, 2025. These $CRNX insider sales rank 8,007th among 11,678 individuals in our database, well below the average of $8.6 million per insider across 6.4 transactions on average. Knight reported no open market purchases in the last 365 days.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 16, 2026 | Crinetics Pharmaceuticals, Inc. | $CRNX | Knight Jeff E. | Chief Operating Officer | S | Common Stock | 3961 | $37.77 | 112,018.0000 | 94,548,000 | 3.42% | 0.00% |
| March 16, 2026 | Crinetics Pharmaceuticals, Inc. | $CRNX | Knight Jeff E. | Chief Operating Officer | S | Common Stock | 5950 | $37.11 | 115,979.0000 | 94,548,000 | 4.88% | 0.01% |
| Feb. 23, 2026 | Crinetics Pharmaceuticals, Inc. | $CRNX | Knight Jeff E. | Chief Operating Officer | A | Stock Option (Right to Buy) | 55000 | $0.00 | 55,000.0000 | 94,548,000 | 9999.99% | 0.06% |
| Feb. 23, 2026 | Crinetics Pharmaceuticals, Inc. | $CRNX | Knight Jeff E. | Chief Operating Officer | A | Common Stock | 34000 | $0.00 | 121,929.0000 | 94,548,000 | 38.67% | 0.04% |
| March 19, 2025 | Crinetics Pharmaceuticals, Inc. | $CRNX | Knight Jeff E. | Chief Operating Officer | S | Common Stock | 6801 | $34.17 | 87,852.0000 | 92,926,000 | 7.19% | 0.01% |
| March 19, 2025 | Crinetics Pharmaceuticals, Inc. | $CRNX | Knight Jeff E. | Chief Operating Officer | S | Common Stock | 361 | $34.83 | 87,491.0000 | 92,926,000 | 0.41% | 0.00% |
| Feb. 20, 2025 | Crinetics Pharmaceuticals, Inc. | $CRNX | Knight Jeff E. | Chief Operating Officer | A | Common Stock | 43000 | $0.00 | 94,653.0000 | 92,926,000 | 83.25% | 0.05% |
| Feb. 20, 2025 | Crinetics Pharmaceuticals, Inc. | $CRNX | Knight Jeff E. | Chief Operating Officer | A | Stock Option (Right to Buy) | 65000 | $0.00 | 65,000.0000 | 92,926,000 | 9999.99% | 0.07% |
| Nov. 22, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Knight Jeff E. | Chief Operating Officer | S | Common Stock | 501 | $56.52 | 51,653.0000 | 68,175,000 | 0.96% | 0.00% |
| July 15, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Knight Jeff E. | Chief Operating Officer | M | Stock option (Right to Buy) | 17499 | $0.00 | 112,501.0000 | 68,175,000 | 13.46% | 0.03% |
| July 15, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Knight Jeff E. | Chief Operating Officer | M | Stock option (Right to Buy) | 2887 | $0.00 | 20,213.0000 | 68,175,000 | 12.50% | 0.00% |
| July 15, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Knight Jeff E. | Chief Operating Officer | M | Stock option (Right to Buy) | 5687 | $0.00 | 85,313.0000 | 68,175,000 | 6.25% | 0.01% |
| July 15, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Knight Jeff E. | Chief Operating Officer | M | Common Stock | 2887 | $20.02 | 72,966.0000 | 68,175,000 | 4.12% | 0.00% |
| July 15, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Knight Jeff E. | Chief Operating Officer | M | Common Stock | 5687 | $19.64 | 78,653.0000 | 68,175,000 | 7.79% | 0.01% |
| July 15, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Knight Jeff E. | Chief Operating Officer | S | Common Stock | 27000 | $55.00 | 51,653.0000 | 68,175,000 | 34.33% | 0.04% |
| July 15, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Knight Jeff E. | Chief Operating Officer | M | Common Stock | 17499 | $23.98 | 70,079.0000 | 68,175,000 | 33.28% | 0.03% |
| June 26, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Knight Jeff E. | Chief Operating Officer | S | Common Stock | 956 | $44.38 | 52,580.0000 | 68,175,000 | 1.79% | 0.00% |
| March 22, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Knight Jeff E. | Chief Operating Officer | S | Common Stock | 2359 | $45.39 | 52,580.0000 | 68,175,000 | 4.29% | 0.00% |
| March 22, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Knight Jeff E. | Chief Operating Officer | S | Common Stock | 30000 | $44.22 | 54,939.0000 | 68,175,000 | 35.32% | 0.04% |
| March 22, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Knight Jeff E. | Chief Operating Officer | M | Common Stock | 30000 | $23.98 | 84,939.0000 | 68,175,000 | 54.61% | 0.04% |
| March 22, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Knight Jeff E. | Chief Operating Officer | M | Stock Option (right to buy) | 30000 | $0.00 | 130,000.0000 | 68,175,000 | 18.75% | 0.04% |
| March 18, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Knight Jeff E. | Chief Operating Officer | F | Common Stock | 4283 | $38.14 | 54,939.0000 | 68,175,000 | 7.23% | 0.01% |
| March 4, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Knight Jeff E. | Chief Operating Officer | A | Common Stock | 23000 | $0.00 | 59,222.0000 | 68,175,000 | 63.50% | 0.03% |
| March 4, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Knight Jeff E. | Chief Operating Officer | A | Stock Option (right to buy) | 87000 | $0.00 | 87,000.0000 | 68,175,000 | 9999.99% | 0.13% |
| Nov. 20, 2023 | Crinetics Pharmaceuticals, Inc. | $CRNX | Knight Jeff E. | Chief Operating Officer | J | Common Stock | 931 | $14.98 | 36,222.0000 | 32,344,371,000 | 2.64% | 0.00% |
| May 22, 2023 | Crinetics Pharmaceuticals, Inc. | $CRNX | Knight Jeff E. | Chief Operating Officer | J | Common Stock | 891 | $14.98 | 35,291.0000 | 0 | 2.59% | 0.00% |
| March 16, 2023 | Crinetics Pharmaceuticals, Inc. | $CRNX | Knight Jeff E. | Chief Operating Officer | F | Common Stock | 587 | $17.12 | 34,400.0000 | 0 | 1.68% | 0.00% |
| March 1, 2023 | Crinetics Pharmaceuticals, Inc. | $CRNX | Knight Jeff E. | Chief Operating Officer | A | Stock Option (right to buy) | 91000 | $0.00 | 91,000.0000 | 0 | 9999.99% | 0.00% |
| March 1, 2023 | Crinetics Pharmaceuticals, Inc. | $CRNX | Knight Jeff E. | Chief Operating Officer | A | Common Stock | 29500 | $0.00 | 34,987.0000 | 0 | 537.63% | 0.00% |
| Nov. 20, 2022 | Crinetics Pharmaceuticals, Inc. | $CRNX | Knight Jeff E. | Chief Operating Officer | J | Common Stock | 537 | $15.16 | 5,487.0000 | 0 | 10.85% | 0.00% |